Bio-Techne Corp (NASDAQ: TECH) has reported E.P.S. of $0.21 for its first fiscal quarter (ending September 30) versus $0.32 for the same period a year ago — a decline of -34%. For the latest four quarters through September 30, E.P.S. were $0.95 compared to $1.57 a year ago — a decline of -39%.
Recent Price Action
Bio-Techne Corp (NASDAQ: TECH) stock closed at $76.02 on 10/30/24 after a very large increase of 7.5%. Moreover, this advance was accompanied by exceptionally high trading volume at 316% of normal. The stock has risen 8.7% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, TECH is expected to continue to be an important Value Builder.
Bio-Techne has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Bio-Techne has a neutral Power Rating of 47 but a poor Appreciation Score of 20, triggering the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment